Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (51-60 of 328) with videos related to

Pageof 33
Sort By:
International Journal of Hematology|December 8, 2025
Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)Shinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
International Journal of Hematology|October 16, 2020
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and costShinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, et al.
Organic Letters|April 29, 2016
Design, Synthesis, and Biological Activity of Isosyringolin AShun Kitahata, Takuya Chiba, Takashi Yoshida, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH geneKaneyuki Ohbayashi, Masafumi Taniwaki, Manabu Ninomiya, et al.
Drugs - Real World Outcomes|August 29, 2021
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance StudyNobuhiro Tsukada, Momoko Nishikori, Hiroaki Goto, et al.
International Journal of Hematology|August 19, 2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)Shinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
International Journal of Hematology|April 6, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM)Shinsuke Iida, Tadao Ishida, Hirokazu Murakami, et al.
BMC Cancer|November 18, 2020
Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective studyMasahiro Kondo, Yuji Hotta, Karen Yamauchi, et al.
International Journal of Hematology|November 29, 2014
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphomaTomotaka Suzuki, Shigeru Kusumoto, Ayako Masaki, et al.
Pathology International|March 26, 2018
Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue studyShusen Han, Ayako Masaki, Yuma Sakamoto, et al.
Pageof 33

Showing results (51-60 of 328) with videos related to

Sort By:
Pageof 33
International Journal of Hematology|December 8, 2025
Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)Shinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
International Journal of Hematology|October 16, 2020
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and costShinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, et al.
Organic Letters|April 29, 2016
Design, Synthesis, and Biological Activity of Isosyringolin AShun Kitahata, Takuya Chiba, Takashi Yoshida, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH geneKaneyuki Ohbayashi, Masafumi Taniwaki, Manabu Ninomiya, et al.
Drugs - Real World Outcomes|August 29, 2021
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance StudyNobuhiro Tsukada, Momoko Nishikori, Hiroaki Goto, et al.
International Journal of Hematology|August 19, 2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)Shinsuke Iida, Shigeki Ito, Kazutaka Sunami, et al.
International Journal of Hematology|April 6, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM)Shinsuke Iida, Tadao Ishida, Hirokazu Murakami, et al.
BMC Cancer|November 18, 2020
Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective studyMasahiro Kondo, Yuji Hotta, Karen Yamauchi, et al.
International Journal of Hematology|November 29, 2014
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphomaTomotaka Suzuki, Shigeru Kusumoto, Ayako Masaki, et al.
Pathology International|March 26, 2018
Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue studyShusen Han, Ayako Masaki, Yuma Sakamoto, et al.
Pageof 33